Ads
related to: acute leukemia treatment- Safety
Learn More About Well Characterized
Safety Profile.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Access & Resources
Support is Available for
You and Your Patients.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Safety
Search results
Celularity Inc. (NASDAQ:CELU) Sees Large Growth in Short Interest
ETF DAILY NEWS· 2 days agoCelularity Inc. (NASDAQ:CELU – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 627,100 shares, a growth of ...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 4 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to...
FierceBiotech· 7 days agoGabrielle Masson, Helen Floersh, James Waldron and Max Bayer contributed reporting to this series....
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating...
Benzinga· 1 day agoOSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5 Philadelphia) Nantes,
90 Day Fiance’s Deavan Clegg Gives Rare Update on Son Taeyang’s Cancer Battle: ‘Thriving’
In Touch Weekly via Yahoo News· 6 days ago90 Day Fiancé alum Deavan Clegg shared a rare update about her son Taeyang's cancer battle while...
New Gene Tests Can Predict if a Drug Will Work for a Patient
Medscape· 6 days agoWhat if there were tests that could tell you whether the following drugs were a good match for your...
Texans WR John Metchie III Named 2024 George Halas Award Winner
Houston Press· 6 days agoWhen you trade up 24 spots into the second round of the NFL Draft to select a player with the 44th...
Dr. Kube: Recent Prozac prescription found to be source of patient's prolonged erection
The Columbus Dispatch via Yahoo News· 4 days agoCraig had some pain relief and was considerably less anxious after receiving IV...relieved. He...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 4 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 6 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Ads
related to: acute leukemia treatment